Patricia Fernández‐Nogueira

Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster et al. · Clinical Cancer Research · 2019 · 109 citations

Medicine, Oncology, Cell Signaling +13

Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer

Susana García‐Recio, Gemma Fuster, Patricia Fernández‐Nogueira et al. · Cancer Research · 2013 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2

Cristina Mayordomo, Susana García‐Recio, Elisabet Ametller et al. · Journal of Cellular Physiology · 2011 · 83 citations

Life Sciences, Oncology, Pharmacology +17

The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

Tatiana Erazo, Mar Lorente, Anna López‐Plana et al. · Clinical Cancer Research · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

Patricia Fernández‐Nogueira, Aleix Noguera‐Castells, Gemma Fuster et al. · Cancer Letters · 2018 · 61 citations · Full text

Medicine, Oncology, Pharmacology +15